Costa BA, Tan CR, Shekarkhand T, et al. Practical use of talquetamab in relapsed/refractory multiple myeloma: the Memorial Sloan Kettering Cancer Center experience. Blood Immunol Cell Ther. 2025;1(2):100005.
Costa BA, Tan CR, Shekarkhand T, et al. Practical use of talquetamab in relapsed/refractory multiple myeloma: the Memorial Sloan Kettering Cancer Center experience. Blood Immunol Cell Ther. 2025;1(2):100005. // Blood Immunology & Cellular Therapy. – URL: https://www.sciencedirect.com/science/article/pii/S3050597626000461?dgcid=rss_sd_all
Costa BA, Tan CR, Shekarkhand T, et al. Practical use of talquetamab in relapsed/refractory multiple myeloma: the Memorial Sloan Kettering Cancer Center experience. Blood Immunol Cell Ther. 2025;1(2):100005. Blood Immunology & Cellular Therapy. https://www.sciencedirect.com/science/article/pii/S3050597626000461?dgcid=rss_sd_all
“Costa BA, Tan CR, Shekarkhand T, et al. Practical use of talquetamab in relapsed/refractory multiple myeloma: the Memorial Sloan Kettering Cancer Center experience. Blood Immunol Cell Ther. 2025;1(2):100005.” Blood Immunology & Cellular Therapy.
@article{article38413,
title = {Costa BA, Tan CR, Shekarkhand T, et al. Practical use of talquetamab in relapsed/refractory multiple myeloma: the Memorial Sloan Kettering Cancer Center experience. Blood Immunol Cell Ther. 2025;1(2):100005.},
journal = {Blood Immunology \& Cellular Therapy},
url = {https://www.sciencedirect.com/science/article/pii/S3050597626000461?dgcid=rss_sd_all}
}
Publication date: November–December 2026 Source: Acta Otorrinolaringologica (English Edition), Volume 77, Issue 6 Author(s): Daniel Álvarez de Castro, Sandra Pérez de la Iglesia, Miguel Ramírez Verdyguer, Francisco José Manzano Gómez